ArticleBreast cancer (Tokyo, Japan)2026

Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.

Hiroki Kusama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.